Interferon signature guiding therapeutic decision making: ruxolitinib as first-line therapy for severe juvenile dermatomyositis?

被引：20

作者：

Heinen, Andre ^{[1
]}

Schnabel, Anja ^{[1
]}

Brueck, Normi ^{[1
]}

Smitka, Martin ^{[2
]}

Wolf, Christine ^{[1
]}

Lucas, Nadja ^{[1
]}

Dollinger, Stefanie ^{[3
]}

Hahn, Gabriele ^{[4
]}

Guenther, Claudia ^{[5
]}

Berner, Reinhard ^{[1
]}

Lee-Kirsch, Min Ae ^{[1
]}

Schuetz, Catharina ^{[1
]}

机构：

[1] Tech Univ Dresden, Dept Pediat, Med Fak Carl Gustav Carus, Fetscherstr 74, D-01307 Dresden, Germany

[2] Tech Univ Dresden, Dept Neuropediat, Med Fak Carl Gustav Carus, Dresden, Germany

[3] Deutsch Zentrum Kinder & Jugendrheumatol, Garmisch Partenkirchen, Germany

[4] Tech Univ Dresden, Dept Radiol, Med Fak Carl Gustav Carus, Dresden, Germany

[5] Tech Univ Dresden, Dept Dermatol, Med Fak Carl Gustav Carus, Dresden, Germany

来源：

RHEUMATOLOGY | 2021年 / 60卷 / 04期

关键词：

D O I：

10.1093/rheumatology/keaa657

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E136 / E138

页数：3

共 8 条

[1] A child with severe juvenile dermatomyositis treated with ruxolitinib [J].

Aeschlimann, Florence A. ;

Fremond, Marie-Louise ;

Duffy, Darragh ;

Rice, Gillian I. ;

Charuel, Jean-Luc ;

Bondet, Vincent ;

Saire, Elsa ;

Neven, Benedicte ;

Bodemer, Christine ;

Balu, Laurent ;

Gitiaux, Cyril ;

Crow, Yanick J. ;

Bader-Meunier, Brigitte .

BRAIN, 2018, 141

[2] Therapeutic Approaches to Type I Interferonopathies [J].

Bienias, Marc ;

Brueck, Normi ;

Griep, Constanze ;

Wolf, Christine ;

Kretschmer, Stefanie ;

Kind, Barbara ;

Tuengler, Victoria ;

Berner, Reinhard ;

Lee-Kirsch, Min Ae .

CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (06)

[3] Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies [J].

Kim, Hanna ;

Gunter-Rahman, Fatima ;

McGrath, John A. ;

Lee, Esther ;

de Jesus, Adriana A. ;

Targoff, Ira N. ;

Huang, Yan ;

O'Hanlon, Terrance P. ;

Tsai, Wanxia L. ;

Gadina, Massimo ;

Miller, Frederick W. ;

Goldbach-Mansky, Raphaela ;

Rider, Lisa G. .

ARTHRITIS RESEARCH & THERAPY, 2020, 22 (01)

[4] Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis [J].

Papadopoulou, Charalampia ;

Hong, Ying ;

Omoyinmi, Ebun ;

Brogan, Paul A. ;

Eleftheriou, Despina .

BRAIN, 2019, 142

[5] Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib [J].

Sabbagh, Sara ;

de Jesus, Adriana Almeida ;

Hwang, Sujin ;

Kuehn, Hye Sun ;

Kim, Hanna ;

Jung, Lawrence ;

Carrasco, Ruy ;

Rosenzweig, Sergio ;

Goldbach-Mansky, Raphaela ;

Rider, Lisa G. .

BRAIN, 2019, 142 :E59-+

[6] Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset [J].

Tansley, Sarah L. ;

Betteridge, Zoe E. ;

Shaddick, Gavin ;

Gunawardena, Harsha ;

Arnold, Katie ;

Wedderburn, Lucy R. ;

McHugh, Neil J. .

RHEUMATOLOGY, 2014, 53 (12) :2204-2208

[7] Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools [J].

Wienke, Judith ;

Deakin, Claire T. ;

Wedderburn, Lucy R. ;

van Wijk, Femke ;

van Royen-Kerkhof, Annet .

FRONTIERS IN IMMUNOLOGY, 2018, 9

[8] Janus kinase inhibition in complement component 1 deficiency [J].

Wolf, Christine ;

Bruck, Normi ;

Koss, Sarah ;

Griep, Constanze ;

Kirschfink, Michael ;

Palm-Beden, Katharina ;

Fang, Mingyan ;

Roeber, Nadja ;

Winkler, Stefan ;

Berner, Reinhard ;

Latz, Eike ;

Guenther, Claudia ;

Lee-Kirsch, Min Ae .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 146 (06) :1439-1442

← 1 →